Clinical Trial

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2

Study acronym: VISION-2
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
VISION-2 is an international, multi-site, prospective observational cohort study of 20,000 patients undergoing noncardiac surgery. Continuous biometric data will be blindly collected for the first 30 postoperative days, in hospital and at home, using Vitaliti™. Following study enrollment and baseline data collection, follow up visits will occur in-hospital, at 30-days, and 1-year post-operatively. VISION-2 has 3 primary objectives, among participants who underwent noncardiac surgery, the investigators will: 1) determine the pattern and frequency of physiological precursors (i.e., biophysical signals) to MINS, BIMS, sepsis, and infection without sepsis; 2) build prediction models from these biophysical signals and their extracted features through supervised machine learning, for the prediction and early detection of those complications; and 3) build a biobank for evaluation of novel biomarkers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-10.
Trial Details
NCT Number NCT07300579
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: McMaster University, Canadian Institutes of Health Research (CIHR), Population Health Research Institute
Conditions Myocardial Injury After Noncardiac Surgery (MINS), Bleeding Independently Associated With Mortality After Noncardiac Surgery (BIMS), Sepsis, Infection Without Sepsis, Post-operative Complications
Enrollment 20,000 participants
Start Date 2026-06
Primary Completion 2031-06 (estimated)
Study Completion 2032-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-14